Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post-Market Clinical Investigation of NanoFUSE® Bioactive Matrix

NCT03762811 is registered in ClinicalTrials.gov with NanoFUSE Biologics, LLC as lead sponsor.

NCT NCT03762811
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03762811 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post-Market Clinical Investigation of NanoFUSE® Bioactive Matrix
Lead sponsor
NanoFUSE Biologics, LLC
Phase
Phase 4
Overall status
Unknown status
Start date
February 28, 2019
Completion date
March 31, 2021
Enrollment
100 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

bone; degeneration